1,(3,)5-substituted imidazoles, their use in the treatment...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 233/60 (2006.01) C07D 233/61 (2006.01) C07D 233/64 (2006.01) C07D 233/66 (2006.01) C07D 403/10 (2006.01) C07D 403/14 (2006.01)

Patent

CA 2687975

The present invention provides novel 1,5 and 1,3,5-substituted imidazole compounds in hydrophilic or lipophilic form, which are useful as angiotensin II ATI receptor antagonists suitable for transdermal delivery. The invention also provides pharmaceutical compositions containing such compounds, processes and intermediates for preparing compounds and their use in methods of treating hypertension and cardiovascular diseases.

L'invention concerne de nouveaux composés d'imidazole 1,5 et 1,3,5-substitutés, sous forme hydrophile ou lipophile, utiles en tant qu'antagonistes des récepteurs ATI de l'angiotensine II, pouvant être administrés par voie transdermique. L'invention concerne également des compositions pharmaceutiques contenant ces composés, des procédés et des intermédiaires pour leur préparation, ainsi que leur utilisation dans des méthodes de traitement de l'hypertension et des maladies cardiovasculaires.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

1,(3,)5-substituted imidazoles, their use in the treatment... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1,(3,)5-substituted imidazoles, their use in the treatment..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,(3,)5-substituted imidazoles, their use in the treatment... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2011626

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.